Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment
Phase 4
Completed
- Conditions
- Smoking CessationSchizophrenia
- Interventions
- Drug: MonotherapyDrug: Combination Bupropion + NRTsOther: Extended TreatmentOther: Home Visits & Calls
- First Posted Date
- 2016-02-08
- Last Posted Date
- 2019-07-30
- Lead Sponsor
- Brentwood Biomedical Research Institute
- Target Recruit Count
- 42
- Registration Number
- NCT02676375
- Locations
- 🇺🇸
West Los Angeles Veterans Affairs Medical Center, Los Angeles, California, United States
Brain Nicotine Receptor Density & Response to Nicotine Patch
Completed
- Conditions
- Cigarette Smoking
- Interventions
- Drug: Transdermal Placebo Patch
- First Posted Date
- 2012-02-03
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- Brentwood Biomedical Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT01526005
- Locations
- 🇺🇸
West Los Angeles Veterans Affairs Medical Center, Los Angeles, California, United States
Rapid Identification of Key Pathogens in Wound Infection by Molecular Means
Completed
- Conditions
- Postoperative Wound InfectionTraumatic Wound InfectionClosed Soft Tissue Abscess
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2012-02-08
- Lead Sponsor
- Brentwood Biomedical Research Institute
- Target Recruit Count
- 400
- Registration Number
- NCT00287599
- Locations
- 🇺🇸
Sydney Finegold, Los Angeles, California, United States
🇺🇸Robert S Bennion MD, Sylmar, California, United States
News
No news found